What Is Ureaplasma? Symptoms, Causes, and When It Actually Matters

Ureaplasma is a type of bacteria that naturally lives in the urogenital tract of up to 70% of sexually active adults. In most cases, it causes no symptoms and requires no treatment. However, when ureaplasma overgrows or is present alongside other risk factors, it can cause urethritis, cervicitis, and pregnancy complications — making the distinction between harmless colonization and active infection critical for treatment decisions.

Few infections generate as much confusion as ureaplasma. In clinical practice, the most common scenario involves a patient who tested positive on a panel, read alarming information online, and now believes they have a serious STD — while their doctor tells them the result may not mean anything. Both perspectives contain truth, and understanding when ureaplasma matters is the key to making informed health decisions.

What Is Ureaplasma, Exactly?

Ureaplasma belongs to the Mollicutes class — the smallest free-living organisms known to science. Unlike most bacteria, ureaplasma lacks a cell wall, which is why standard antibiotics like penicillin and amoxicillin have no effect on it. Two species are relevant to human health: Ureaplasma urealyticum and Ureaplasma parvum. Of the two, U. urealyticum is more strongly associated with causing symptoms, while U. parvum is generally considered a harmless colonizer (Medscape, 2024).

These organisms are primarily transmitted through sexual contact but can also pass from mother to infant during delivery. Ureaplasma colonization is remarkably common — research published in Frontiers in Public Health found that approximately 70% of sexually active individuals carry ureaplasma without any symptoms (Wang et al., 2023). This high baseline colonization rate is precisely what makes diagnosis and treatment decisions complex.

Is Ureaplasma an STD?

This is the question that drives most patients to search online — and the answer requires nuance. Ureaplasma is sexually transmitted, but it does not behave like a classic STD. Unlike chlamydia or gonorrhea, where a positive test almost always means active infection requiring treatment, a positive ureaplasma test frequently reflects normal colonization rather than disease.

The CDC does not include ureaplasma in its standard STD screening recommendations. In its STI Treatment Guidelines, the CDC specifically notes that routine testing for U. urealyticum is not recommended for asymptomatic individuals. This is a critical distinction: ureaplasma testing should generally be driven by symptoms, not by routine screening.

In practical terms, think of ureaplasma as an opportunistic organism. It lives quietly in the urogenital tract of most sexually active people. It becomes clinically relevant only when it causes symptoms — typically urethritis in men, cervicitis in women, or complications during pregnancy.

What Symptoms Does Ureaplasma Cause?

Most people with ureaplasma experience no symptoms at all. When symptoms do appear, they tend to be subtle and easily mistaken for other conditions:

In women:

• Unusual vaginal discharge (clear or slightly cloudy)

• Burning or discomfort during urination

• Pelvic pain or discomfort

• Pain during intercourse

• Cervicitis (inflammation of the cervix, often found incidentally during exams)

In men:

• Clear or whitish urethral discharge

• Burning sensation during urination

• Urethral irritation or itching

• Less commonly: testicular pain or swelling (epididymitis)

The overlap with chlamydia and gonorrhea symptoms is significant, which is why many clinicians test for ureaplasma only after standard STD tests come back negative but symptoms persist. A 2024 review in the Journal of Urgent Care Medicine emphasized that ureaplasma should be considered in cases of recurrent non-gonococcal urethritis that fails to respond to first-line treatment.

How Do You Get Ureaplasma?

Ureaplasma spreads primarily through:

• Vaginal or anal intercourse — the most common route of transmission between adults

• Oral sex — less common but documented

• Vertical transmission — from mother to infant during vaginal delivery

Unlike some STDs, ureaplasma does not spread through casual contact, toilet seats, shared towels, swimming pools, or respiratory droplets. The bacteria requires direct mucous membrane contact to transmit.

An important clinical reality: because ureaplasma is so common among sexually active adults, a positive test does not necessarily indicate recent sexual exposure or infidelity. A person can carry ureaplasma asymptomatically for months or even years after initial acquisition. This is a crucial point for patients navigating relationship concerns after a diagnosis — and one that is often overlooked in standard STD education.

Can Ureaplasma Cause Infertility?

This is where ureaplasma becomes clinically significant beyond acute symptoms. Research has linked ureaplasma — particularly U. urealyticum — to several reproductive health concerns:

In women:

• Increased risk of preterm birth and premature rupture of membranes

• Chorioamnionitis (infection of the amniotic membranes)

• Post-abortion or postpartum endometritis

• Potential contribution to recurrent miscarriage (evidence is growing but not yet conclusive)

In men:

• A 2025 systematic review and meta-analysis published in Basic and Clinical Andrology found that U. urealyticum infection was significantly associated with increased seminal fluid leukocytes and decreased sperm motility, concentration, and morphology (Kukoyi et al., 2025)

• Epididymitis and prostatitis linked to ureaplasma may also contribute to fertility impairment

For couples struggling with unexplained infertility or recurrent pregnancy loss, testing for ureaplasma — and treating it if found — is a reasonable step that many fertility specialists now include in their workup.

How Is Ureaplasma Diagnosed?

Ureaplasma is not detected by standard STD panels. If your doctor runs a typical STD screen for chlamydia, gonorrhea, syphilis, and HIV, ureaplasma will not be included. Specific testing must be requested.

Two diagnostic approaches are available:

• Nucleic Acid Amplification Test (NAAT/PCR) — the preferred method. Detects ureaplasma DNA with high sensitivity and can distinguish between U. urealyticum and U. parvum. This distinction matters because U. urealyticum is more likely to be clinically significant.

• Culture — can grow ureaplasma from urine, urethral, vaginal, or cervical samples. Takes longer than PCR but can provide antibiotic susceptibility data, which is valuable when resistance is suspected.

Testing is typically performed on a urine sample (men) or vaginal/cervical swab (women). Results are usually available within 2 to 5 business days depending on the laboratory.

How Is Ureaplasma Treated?

Not every positive ureaplasma test requires treatment. Current clinical consensus, aligned with CDC guidance, is to treat only when ureaplasma is accompanied by symptoms or when it is identified as the probable cause of a clinical syndrome (urethritis, cervicitis, or pregnancy complications).

When treatment is indicated, the first-line option is:

• Doxycycline 100 mg twice daily for 7 days — effective against most ureaplasma strains

If doxycycline fails or the patient cannot take tetracyclines (such as during pregnancy), alternatives include:

• Azithromycin — a macrolide option, though resistance is increasing

• Moxifloxacin — reserved for resistant cases due to its broader side-effect profile

• Erythromycin — sometimes used in pregnancy when doxycycline is contraindicated

A U.S. surveillance study examining 415 clinical isolates of ureaplasma found resistance rates of 2.4% for erythromycin, 6.5% for tetracycline, and 6.7% for levofloxacin — suggesting that while resistance exists, doxycycline remains effective for the vast majority of cases.

Sexual partners should be evaluated and treated simultaneously to prevent reinfection. Patients should abstain from sexual activity until both partners have completed treatment. For detailed guidance on post-treatment considerations, see our guide on when to retest after STI treatment.

When to Seek Urgent Care

While ureaplasma is rarely a medical emergency, certain situations require prompt evaluation:

• Recurrent urethritis not responding to chlamydia or gonorrhea treatment — ask your doctor to test specifically for ureaplasma and mycoplasma genitalium

• Ureaplasma positive during pregnancy — treatment should be initiated to reduce the risk of preterm birth and neonatal complications

• Recurrent miscarriages with no identified cause — request ureaplasma testing as part of your fertility workup

• Testicular pain or swelling — could indicate epididymitis requiring targeted antibiotic therapy

• Treatment failure after completing doxycycline — may indicate antibiotic resistance requiring alternative agents like moxifloxacin

Frequently Asked Questions

Should I be worried about a positive ureaplasma test?

Not necessarily. Ureaplasma is found in the urogenital tract of the majority of sexually active adults. A positive test without symptoms usually means colonization, not infection. If you have no symptoms, your doctor may recommend monitoring rather than treatment. If symptoms are present — burning during urination, unusual discharge, pelvic pain — treatment is straightforward and effective.

Can ureaplasma go away on its own?

Ureaplasma colonization can fluctuate over time, and some individuals may clear the organism without antibiotics. However, when ureaplasma is causing active symptoms, spontaneous resolution is uncommon and treatment is recommended to prevent complications and ongoing transmission to partners.

Can you get ureaplasma without cheating?

Yes. Ureaplasma can persist asymptomatically for months or years after initial acquisition. A positive result does not indicate when the infection was acquired or from whom. Many people carry ureaplasma from previous sexual contacts long before their current relationship.

Is ureaplasma the same as mycoplasma?

No, though they are closely related. Both belong to the same bacterial family (Mycoplasmataceae) and share similar characteristics — including the lack of a cell wall. However, they are different organisms with different clinical implications. Mycoplasma genitalium, in particular, is more consistently pathogenic than ureaplasma and has different treatment protocols. For a detailed comparison, see our guide on mycoplasma genitalium.

How often should you test for ureaplasma?

Routine screening for ureaplasma is not recommended for the general population. Testing is appropriate when you have persistent urogenital symptoms that standard STD tests have not explained, when you are experiencing recurrent pregnancy loss, or when a sexual partner has been diagnosed with symptomatic ureaplasma infection.

Can ureaplasma affect fertility?

Current evidence suggests that U. urealyticum can impair sperm quality in men and may contribute to pregnancy complications in women. A 2025 meta-analysis found significant associations between U. urealyticum and reduced sperm motility and concentration. For couples undergoing fertility treatment, testing for and treating ureaplasma is increasingly included in standard protocols.

The Bottom Line

Ureaplasma occupies a unique space in sexual health — it is extremely common, usually harmless, but occasionally clinically significant. The key takeaway is that a positive test alone does not mean you have a disease. Context matters: symptoms, pregnancy status, fertility concerns, and clinical presentation all determine whether treatment is necessary. If you are experiencing persistent urogenital symptoms or have concerns about ureaplasma, the most productive step is getting tested with a comprehensive panel and discussing results with a healthcare provider who understands the nuances of this organism.